RGEN

Repligen

Stock NASDAQ – Stock Market Prices, News & Analysis

Repligen Corp développe et commercialise des produits biotechnologiques, principalement pour la fabrication de médicaments biologiques.

$ 135.40
0.21 %

Repligen

$ 135.40
0.21 %
RGEN

Repligen Corp développe et commercialise des produits biotechnologiques, principalement pour la fabrication de médicaments biologiques.

Price history of Repligen
Price history of Repligen

Performance & Momentum

6 Months 9.13 %
1 Year 6.73 %
3 Years 23.93 %
5 Years 36.83 %
Momentum
79

Similar stocks to Repligen

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone